If Sam Altman returns to his position, Microsoft is considering joining the OpenAI board of directors
阿豆学长长ov
发表于 2023-11-20 13:12:21
257
0
0
On November 20th, The Information reported, citing two sources familiar with the matter, that if dismissed CEO Sam Altman returns to his position, Microsoft will consider taking a seat on the OpenAI board. According to insiders, Microsoft can hold a seat on the OpenAI board or serve as an observer on the board without voting rights.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Paijie Investment lowers Microsoft's target price from $485 to $470 to maintain its overweight rating
- 파이저 투자, 마이크로소프트 목표가 485달러에서 470달러로 하향 조정, 초배정 등급 유지
- OpenAI and Microsoft seem to be on the same page, but they are apart? It is said that potential "breakup clauses" have already been included in the contract between the two parties
- NVIDIA explodes with explosive materials! Guo Mingchi: Microsoft Q4 GB200 chip orders surge 3-4 times
- Microsoft adds autonomous agent functionality to Copilot Studio International Edition
- Before the US stock market, the three major futures indexes slightly rose, and well-known Chinese concept stocks generally rose; Wenyuan Zhixing restarts IPO in the United States with a maximum valuation of about 5 billion US dollars; Fashion luxury
- Microsoft's first quarter report: double-digit growth in performance, expected slowdown in growth of cloud business Azure
- 마이크로소프트 1분기 보고서: 실적 두 자릿수 성장, 클라우드 사업 Azure 성장 기대 둔화
- Top 20 US Stock Exchange Transactions: Microsoft Falls Over 6% After Results, Largest Single Day Drop in Two Years
- icrosoft는 2025년 10월 14일에 Windows 10 시스템에 대한 지원 서비스를 종료한다고 공식 발표했습니다.
-
アップル（AAPL）は現地時間10月31日、9月28日までの2024年第4四半期の業績を発表し、同四半期の売上高は前年同期比6%増の949億3000万ドル、純利益は同36%減の147億3600万ドルだった。 純利益の下落は主に102億ドル ...- 亲亲宝宝贝贝贾
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【英偉達の需要が高すぎる？SKハイニックス：黄仁勲がHBM 4チップの6カ月前納入を要求！】SKハイニックスの崔泰源（チェ・テウォン）会長は月曜日、インビダーの黄仁勲（ファン・インフン）CEOが同社の次世代高帯域 ...- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;（TALZENNA®，一般名：トルエンスルホン酸タラゾールパーリカプセル）は2024年10月29日に国家薬品監督管理局（NMPA）の承認を得て、HRR遺伝子突然変異 ...- 什么大师特
- 1 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...- Dubssgshbsbdhd
- 2 小时前
- 支持
- 反对
- 回复
- 收藏
